Videos

Follicular Lymphoma: Treating Early Progressors

Thomas Marron, MD, discusses the rationale for investigating immunotherapy discontinuation in patients with melanoma.

Winston Tan, MD, discusses the emergence of novel agents for the treatment of patients with gastrointestinal stromal tumors, namely agents like avapritinib and ripretinib, which have shown promise in ongoing clinical trials.<br /> &nbsp;